All News
Day 2 Report from ACR21
This report highlights the VITAL trial; the ORAL Surveillance Study; and the Microbiome study of monozygotic psoriasis patients.
Read Article
Axial spondyloarthritis with psoriasis or psoriatic spondylitis
PsA commonly affects peripheral joints. In up to a quarter of PsA patients, the spine may be involved and this is known as psoriatic spondylitis (PsSpA). An important research question is whether PsSpA and Axial Spondyloarthritis (AxSpA) with psoriasis are separate conditions or not.
Read Article
Interesting results where cannabidiol NEG results in RCT in hand OA and PsA. ? Throw out the ‘pot’with the dish water? Did it stimulate appetites? Was pain the same but interference less? Abst#1456 #ACR21 @RheumNow https://t.co/rnz82Paxkr
Janet Pope Janetbirdope ( View Tweet)
Interesting question came up: why would you change a RA patient from JAKi to JAKi?
The main reason I can think of would be if the first JAKi worked a bit (but not enough to continue, or AEs got in the way).
That would clearly favour to better survival
#ACR21 ABST1442 @RheumNow https://t.co/kDiJVbJfit
David Liew drdavidliew ( View Tweet)
#ACR21 #Abstr1484 Hands down one of the most impressive results and trial design. RHAPSODY: Rilonacept led to ⬇️risk of pericarditis recurrence vs PBO (7% vs 74%; HR 0.04). Median time to resolution of pain and CRP were 5 & 7 Days. FDA approved @RheumNow https://t.co/Zty2WnkJEQ https://t.co/xGqt9Lwvjj
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
RheumNow’s expanded coverage of the #ACR21 meeting is sponsored in part by @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush RheumNow ( View Tweet)
Realised i have not been out of house apart from hospital visits 😳🙈#MeTime outdoor in the UK 🇬🇧 Falls season while enjoying #ACR21 talks by the New Masters @RheumNow #Rheumpix https://t.co/HYLKkECvCv
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Loved this session on: Preclinical Rheumatoid Arthritis- Can we stop RA? As a patient advocate living with RA, my providers have always ran tests on my microbiome. The findings have correlated with my disease flares, and was a big trigger overall. #ACR21 @ACRheum Thank you! https://t.co/6hm6hr85JS
Effie Koliopoulos RisingAboveRa ( View Tweet)
Erdheim Chester Disease
👉A histiocytic,myeloid malignancy
👉 “Coated Aorta” Classic peri-aortitis inv. Thoracic & Abdominal Aorta
👉 “Hairy Kidneys” on CT
👉 Abn PET-CT, foamy histiocytes on path
👉 Refer to onc for t/t
#ACR21 ✨Must See✨ session on Pearls by Dr. John Stone!! https://t.co/qobSsPxAhY
Ashima Makol MD AshimaMakol ( View Tweet)
So humbled and honored
Thank you ACR /RRF for the constant support
#ACR21 https://t.co/SAE6ZfYmm5
swethaann23 swethaann23 ( View Tweet)
Dr. Fujimoto provides a wonderful overview of skin findings in DM by antibody
#ACR21 #ACRAmbassador https://t.co/KpOsgKPU7j
Veena Katikineni VeenaRheumMD ( View Tweet)
#ACR21 Rheumatology Secrets & Pearls: @JKolfenbach & Dr. Stone 📚
Unique Pearls Discussed ⬇️
🩺 Auscultate bruits on the back
💊 Oxypurinol levels
🍓 Strawberry-like gingivitis
👃 Human neutrophil elastase (HNE)
♥️ Coronary aneurysm in IgG4-RD
@ACRheum #ACRAmbassador https://t.co/gTyrmUA10r
Mithu Maheswaranathan, MD MithuRheum ( View Tweet)
#ACR21
#pedsrheum
Risk factors for poor outcomes: delay to diagnosis, poor access to therapy, poor access to care https://t.co/SlFyav5KV6
Dr. Laura Lewandowski LauraLewMad11 ( View Tweet)
"CH COVID-19: Office Hours: COVID-19 Vaccine in Immune-mediated Inflammatory Disease (IMID) Patients" #ACR21
A great thing about @ACRheum's Convergence is being able to listen to conversations about important topics like booster type & timing specifically for #rhum patients https://t.co/horwWeAen7
International Foundation AiArthritis IFAiArthritis ( View Tweet)
Dr. Petri on SLE, Vit D, and BMD
~1k pts, 92% fem, 42% Black, 48% White
Freq. of osteoporosis:
💠M ~ F
💠Black ~ White
💠⬆️in smokers
Lumbar BMDs showed:
💠Vit D level w/Paradoxical effect
💠Rec goal of 40ng/mL in SLE
https://t.co/kBylQAwqhD
#ACR21 Abst#1265 #ACRBest @RheumNow
Pedro Castillo _Castillo_Pedro ( View Tweet)
#ACR21 #Abstr1462 More case against Low dose Hydroxychloroquine as could ⬆️ risk of #lupus flares. Adjusted risk as below:
Weight =>80kg, <400mg/d dose (OR 8.3)
Weight <80kg, <300mg/d dose (OR 2.6) @RheumNow https://t.co/bTRMJDoSoI https://t.co/yzopiO3Kbo
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Post hoc analysis of BLISS-LN 🦋
Pts who didn't receive steroid pulses at induction 👇
🔸⬆ PERR & CRR responders, ⬇mean daily pred doses, more pts had ave daily pred <=5mg or <=7.5mg for both BEL & PBO
🔸BEL grp ⬇ flares/kidney-related death
@RheumNow #ACR21 #ACRBest abs1461 https://t.co/ev0LK7d6oL
sheila RHEUMarampa ( View Tweet)
Dr. Furie asked Dr. Touma what he was doing in 1976? Dr. Touma said, "I was not even in school, yet." Dr. Furie noted that in 1976, the first study was published on methylprednisolone pulse for lupus nephritis in 7 patients. #ACR21 @rheumnow Link below https://t.co/Oe9xmH7Tzg https://t.co/xslAHYNXej
TheDaoIndex KDAO2011 ( View Tweet)
#ACR21 Ab#1166. How many of your pts use marijuana?
⭐️Probably more than you think!
▶️57% have tried, >50% use at least weekly
▶️67% doctors thought <20% of pts use it
🔥Pts over 40 yo MORE likely to report marijuana use
@Rheumnow https://t.co/0uW8rZvf1k https://t.co/ShMnR0faHr
Links:
Eric Dein ericdeinmd ( View Tweet)
#ACR21 #Abstr1461 Post-hoc analyses from BLISS-LN #lupus showed independent of IV Steroid pulses during induction, at Wk104:
💠More pts in Belimumab achieved PERR and CR vs PBO
💠More pts in PBO had flares and kidney event/death vs BEL
@RheumNow https://t.co/pLxAI2RDRJ https://t.co/8CZMq3RTls
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)